FFAR3 and inflammatory bowel disease: This may be particularly pertinent in the context of IBD, which is often accompanied by dysbiosis characterized by loss of SCFA-producing species of bacteria.5,20 The data herein support this position, revealing preservation of mitochondrial form/function in the face of infection with an AIEC as another benefit of butyrate, achieved, at least in part, through FFAR3.